Mesothelioma News



www.mirg.org
Mesothelioma - What is it?
Where Do I Go From Here?
Clinical Trials
Types of Mesothelioma
   >Pleural Mesothelioma
   >Peritoneal Mesothelioma
Mesothelioma clinical signs?
Mesothelioma Diagnosis
Choosing a Doctor
   >Doctor Worksheet
   >Clinical Trial Worksheet
Mesothelioma Treatments
Mesothelioma Lawyer
Mesothelioma Imagery
Mesothelioma Related
Occupations

Asbestos Cancer
Mesothelioma News
Mesothelioma News adobe .PDF



Mesothelioma Information and Resource Group on the symptoms, treatments and clinical signs

Mesothelioma News
Latest Articles
View PDFPDF Version articles here


New - PDF Version Extrapleural Pneumonectomy, IHOC Cisplatin and Gemcitabine With Amifostine and Sodium Thiosulfate Cytoprotection for Resectable Malignant Pleural Mesothelioma
April 28, 2008

PDF Version Pazopanib in Treating Patients With Malignant Pleural Mesothelioma
September 21, 2007

PDF Version Trial of Cisplatin, Imatinib Mesylate, and Pemetrexed in Malignant Mesothelioma Patients
November 28, 2006

PDF Version Vaccine Therapy and GM-CSF in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, or Mesothelioma
November 28, 2006

PDF Version Virus linked to cancer caused by asbestos
November 12, 2006

PDF Version Antineoplaston Therapy in Treating Patients With Advanced Mesothelioma
October 12, 2006

PDF Version Merck & Co: Zolinza becomes first approved HDAC inhibitor
October 10, 2006

PDF Version Alfacell Completes Non-Clinical Section of Rolling NDA for Lead Anticancer Drug ONCONASE
October 2, 2006

PDF Version Oncology Researchers Recognized As Heroes Of Chemistry
September 12, 2006

PDF Version Combination Chemotherapy With or Without Surgery and Chemoradiotherapy in Treating Patients With Malignant Pleural Mesothelioma
September 6, 2006

PDF Version Alimta® Alone or with Platinol® Benefits Patients with Recurrent Mesothelioma>
August 11, 2006

PDF Version Pemetrexed Disodium and Either Gemcitabine or Carboplatin in Treating Patients With Advanced Malignant Pleural Mesothelioma
August 11, 2006

PDF Version Clinical Trial: A Study of MORAb-009 in Subjects With Pancreatic Cancer, Mesothelioma, or Certain Types of Ovarian or Lung Cancer
July 20, 2006

PDF Version Alfacell Provides Update on the ONCONASE Phase IIIb Registration Trial for Mesothelioma
June 22, 2006

PDF Version CuraGen and TopoTarget Announce Initiation of NCI-sponsored Phase II Clinical Trial with PXD101 for Mesothelioma
June 20, 2006

PDF Version Asbestos linked to larynx cancer
June 7, 2006

PDF Version Clinical Trial Confirms Novel EGFR Antibody Targets Tumors But Not Normal Tissues
June 5, 2006

PDF Version ZIOPHARM Presents Preliminary ZIO-201 Clinical Results at ASCO
June 5, 2006

PDF Version Encouraging Phase I Trial Results for XL647 in Patients with Advanced Solid Malignancies Presented at ASCO
June 3, 2006

Click here PDF Article Home for PDF Article Home

Google News Search : Mesothelioma




MIRG.org 1-888-802-6376 e-mail

www.MIRG.org Site Map About Us Contact Us Links Disclaimer

Mesothelioma Information Resource Group, MIRG.org, tries to assist individuals and families in learning about mesothelioma and other asbestos related injuries. It is the aim of MIRG.org to provide an account of the disease mesothelioma, its causes, various treatment options and potential legal impact. To find out more about Mesothelioma and other asbestos related diseases, new medical advances, and clinical trials now available please use the links provided.
The information on this website is presented by the Mesothelioma Information Resource Group and is for informational purposes only. No particular course of treatment is suggested. All persons are advised to consult with a medical doctor concerning treatment of mesothelioma or any illness. Also, nothing on this website is intended to constitute legal advice by a lawyer or attorney. Note disclaimer.